🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a prospective, multicenter, open label extension (OLE) trial on th...
Status
Terminated
Location
Investigator site 115 - US0010086
Start Date
2021-07-15
Trial ID
NCT04598477
Treatments Being Tested
The purpose of this study is to evaluate the safety of efgartigimod PH20 SC...
Status
Terminated
Location
Medical Dermatology Specialists
Start Date
2023-03-22
Trial ID
NCT05681481
Treatments Being Tested
This is a phase 3, multicenter, randomized, double-blinded, placebo-control...
Status
Completed
Location
Investigator Site 0010116
Start Date
2020-12-16
Trial ID
NCT04687072
Treatments Being Tested
A Phase 3 study to evaluate the safety and efficacy of efgartigimod PH20 su...
Status
Active Not Recruiting
Location
Investigator Site 0010116
Start Date
2021-11-17
Trial ID
NCT04812925
Treatments Being Tested
The aim of this trial is to investigate the pharmacodynamic (PD), pharmacok...
Status
Completed
Location
Investigator Site
Start Date
2019-07-17
Trial ID
NCT04073589
Treatments Being Tested
The POLARIS study is designed to evaluate how well efgartigimod PH20 SC may...
Status
Recruiting
Location
Center for Neurosciences
Start Date
2026-08-15
Trial ID
NCT07583641
Treatments Being Tested
The main purpose of this study is to measure the long-term safety and toler...
Status
Enrolling By Invitation
Location
Neuromuscular Clinical and Research Center - Neurology
Start Date
2023-09-12
Trial ID
NCT05979441
Treatments Being Tested
This is the open-label extension study of phase II ARGX-113-1802 to evaluat...
Status
Active Not Recruiting
Location
Investigator site 0010065
Start Date
2020-09-18
Trial ID
NCT04280718
Treatments Being Tested